Enter
PrivateLast Round
Series B
May 5, 2026
Est. Valuation
$1.2B
Total Funding Raised
$140.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Enter is a legal technology company that provides an AI-driven platform to help enterprises manage mass litigation by automating processes such as case intake, fraud detection, and drafting defenses.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Vertical SaaS, Medical AI, Workflow Automation
Business Model
B2B
Customer Profile
Revenue Share, Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enter Comparables
Compare Enter with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Candid Health | 87% | |
| Adonis | 81% | |
| Amperos Health | 80% | |
Enter Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 5, 2026 | ||||
| Series A | Sep 24, 2025 | ||||
| Seed | Mar 11, 2025 | ||||
| Pre Seed | Nov 1, 2023 |
Enter Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NFX | Series A |
| Founders Fund | Series A, Series B |
| ONEVC | Series A, Series B, Seed, Pre Seed |
| Pear VC | Series A |
| Sequoia Capital | Series B, Series A, Seed |
| Riverwood Capital | Series A |
| Ribbit Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2026
$100M round led by Founders Fund.
- Sep 24, 2025
$35M round led by Founders Fund and Sequoia Capital.
Enter Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enter's valuation, stock price, and market status.